Clinical Trials on Optic Nerve Hypoplasia and Abnormalities of the Central Nervous System in Poland

Total 1174 results

Hoffmann-La Roche

Recruiting

A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) (SAkuraSun)

Neuromyelitis Optica Spectrum Disorder | NMOSD

Poland, United Kingdom, Argentina, Italy, France, United States
Amgen

Recruiting

Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD) (N-MOmentum LT)

Neuromyelitis Optica Spectrum Disorder

Korea, Republic of, Thailand, Hong Kong, Hungary, Poland
Amgen

Recruiting

Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder

Neuromyelitis Optica Spectrum Disorder

United Kingdom, United States, Sweden, Netherlands
Hoffmann-La Roche
Chugai Pharmaceutical

Completed

Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)

Neuromyelitis Optica (NMO) | NMO Spectrum Disorder (NMOSD)

Spain, Italy, United States, Japan, Poland, Taiwan, Germany, United Kingdom, Hungary, France, Ukraine
Hoffmann-La Roche

Active, not recruiting

A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Neuromyelitis Optica Spectrum Disorder

United States, Spain, United Kingdom, Taiwan, Hungary, Korea, Republic of, Japan, Croatia, Bulgaria, Canada, Germany, Italy, Poland, Puerto Rico, Romania, Turkey, Ukraine, Malaysia
MedImmune LLC

Completed

N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders

Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders

United States, Czechia, Thailand, Germany, Korea, Republic of, Israel, New Zealand, Spain, Taiwan, Japan, Turkey, Hungary, Bulgaria, Mexico, Russian Federation, Colombia, Peru, Poland, Estonia, South Africa, Canada, Australia, Hong... and more
Alexion

Active, not recruiting

An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD

Neuromyelitis Optica | Neuromyelitis Optica Spectrum Disorder

United States, Australia, Austria, Canada, Denmark, France, Germany, Italy, Japan, Korea, Republic of, Poland, Spain, United Kingdom
Hoffmann-La Roche
Chugai Pharmaceutical

Completed

Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)

Neuromyelitis Optica (NMO) | NMO Spectrum Disorder (NMOSD)

United States, Korea, Republic of, Malaysia, Turkey, Bulgaria, Canada, Poland, Puerto Rico, Romania, Croatia, Georgia, Italy, Philippines, Taiwan, Ukraine
Medical University of Bialystok
University of Bialystok

Recruiting

Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy.

Optic Neuritis | Ischemic Optic Neuropathy | Traumatic Optic Neuropathy | Toxic Optic Neuropathy | Compressive Optic Neuropathy | Hereditary Optic Neuropathies

Poland
National Eye Institute (NEI)

Unknown

Longitudinal Optic Neuritis Study (LONS)

Multiple Sclerosis | Optic Neuritis

United States
National Eye Institute (NEI)

Unknown

Optic Neuritis Treatment Trial (ONTT)

Multiple Sclerosis | Optic Neuritis

United States
Oregon Health and Science University

Completed

Lipoic Acid as a Treatment for Acute Optic Neuritis

Optic Neuritis

United States
Santhera Pharmaceuticals

Completed

Study to Assess the Efficacy and Safety of Raxone in LHON Patients (LEROS)

Leber's Hereditary Optic Neuropathy (LHON)

United States, United Kingdom, Spain, Poland, Austria, Belgium, Bulgaria, Germany, Italy, Portugal
Military Institute of Medicine, Poland
Medical University of Warsaw; Indiana University School of Medicine; Polish Academy...

Completed

Autonomic Nervous System Activity and Normal Tension Glaucoma (ANS)

Normal Tension Glaucoma

Poland
Eli Lilly and Company

Completed

A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors

Nonarteritic Anterior Ischemic Optic Neuropathy

United States
Medical University of Lublin

Completed

Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy.

Eye Diseases | Glaucoma Surgery | Optic Nerve Damage

Poland
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION

Optic Neuropathy, Ischemic

United States, Spain, Germany, Italy, France, United Kingdom
OHSU Knight Cancer Institute
Oregon Health and Science University; Celgene Corporation

Recruiting

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

Metastatic Malignant Neoplasm in the Brain | Central Nervous System Neoplasm | Cranial Nerve Disorder

United States
Maastricht Radiation Oncology
University Medical Center Groningen; Erasmus Medical Center; Leiden University... and other collaborators

Recruiting

Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology

Astrocytoma | Adenoma | Ependymoma | Nerve Sheath Neoplasms | Ganglioglioma | Oligodendroglioma | Meningioma | Hemangiopericytoma | Craniopharyngioma | Germinoma | Neurilemmoma | Optic Nerve Glioma

Netherlands
Sensimed AG

Completed

Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG

Primary Open Angle Glaucoma | Normal Tension Glaucoma

Poland
University of Birmingham

Active, not recruiting

Efficacy and Safety Trial of Sodium Valproate, in Paediatric and Adult Patients With Wolfram Syndrome

Wolfram Syndrome

France, United Kingdom, Poland, Spain
National Cancer Institute (NCI)

Completed

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Brain Stem Neoplasm | Pineal Region Neoplasm | Recurrent Visual Pathway Glioma | Refractory Visual Pathway Glioma

United States
PTC Therapeutics

Completed

A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy (MIT-E)

Mitochondrial Diseases | Drug Resistant Epilepsy | Leigh Disease | Leigh Syndrome | Mitochondrial Encephalopathy (MELAS) | Pontocerebellar Hypoplasia Type 6 (PCH6) | Alpers Disease | Alpers Syndrome

United States, Spain, United Kingdom, Canada, France, Italy, Poland, Sweden, Japan
Merck KGaA, Darmstadt, Germany

Completed

An Observational Study to Evaluate Quality of Life (QoL) and Influence of Cognitive Status on QoL in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) During 2 Years Treatment With Rebif New Formulation (RNF) (MusiClock)

Multiple Sclerosis, Relapsing-Remitting

Poland
Pomeranian Medical University Szczecin

Completed

Sensory Integration Disorders in Patients With MS Including Disease Advancement and Relapses in the Last Year

Multiple Sclerosis

Poland
Pomeranian Medical University Szczecin

Terminated

Influence of Cognitive Function Software Therapy on the Improvement of Manual Skills in Multiple Sclerosis Patients

Multiple Sclerosis

Poland
US Department of Veterans Affairs

Terminated

Lokomat Training Effects on MS Gait Abnormalities

Multiple Sclerosis

United States
Bayer

Completed

Depression and Fatigue in MS Patients Treated With Betaferon. (FADO)

Multiple Sclerosis

Poland
GlaxoSmithKline

Completed

Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting

Belgium, Germany, Russian Federation, Spain, Poland
Bayer

Completed

Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE) (INFLUENCE)

Multiple Sclerosis

Poland
Jagiellonian University

Recruiting

Sensitivity of Repetitive Nerve Stimulation Performed in the Evening vs in the Morning in Myasthenia Gravis

Myasthenia Gravis

Poland
Bayer

Completed

Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis (BREAK)

Multiple Sclerosis

Poland
Jagiellonian University
Piotr Chlosta, Full-time Professor, University Hospital, Cracow, Poland

Completed

Polish Translation and Validation of NBSS, Qualiveen and SF-Qualiveen

Multiple Sclerosis | Spinal Cord Injuries

Poland
Katarzyna Kotulska

Recruiting

Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex (RaRE-TS)

Tuberous Sclerosis Complex

Poland
Euromedic Specialist Clinics, Poland

Completed

Endovascular Treatment for Chronic Cerebrospinal Venous Insufficiency (CCSVI)

Multiple Sclerosis

Poland
Legacy Health System
DUSA Pharmaceuticals, Inc.

Unknown

A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain (ALA)

Glioma

United States
Oregon Health and Science University

Active, not recruiting

Effect of Abdominal Wall Injections on Abdominal Pain

Anterior Cutaneous Nerve Entrapment Syndrome

United States
Jakub Antczak

Completed

Median Nerve Stenosis in Carpal Tunnel Syndrome

Carpal Tunnel Syndrome

Poland
Celltrion

Recruiting

A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis

Relapsing-remitting Multiple Sclerosis

Poland
GlaxoSmithKline

Completed

Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients

Multiple Sclerosis

Poland, Germany, Czechia
Katarzyna Kotulska

Recruiting

Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants (ViRap)

Tuberous Sclerosis Complex

Poland
MorphoSys AG

Completed

Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis

Multiple Sclerosis

Germany, Poland, United Kingdom
Medical University of Lodz

Completed

Serum Copeptin as a Predictor of the Risk of Hyponatremia After Transurethral Prostatectomy

Benign Prostatic Hyperplasia

Poland
Catalyst OrthoScience

Recruiting

Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty

Osteoarthritis Shoulder | Avascular Necrosis of the Head of Humerus | Rheumatoid Arthritis Shoulder

United States
Oregon Health and Science University

Completed

Exercise & Brain Health in MS

Multiple Sclerosis

United States
Oregon Health and Science University
Portland VA Medical Center

Completed

A Randomized Controlled Trial of a Multicomponent Walking Aid Program for People With MS (ADSTEP)

Multiple Sclerosis

United States
Merz Pharmaceuticals GmbH

Completed

A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the Arm

Essential Tremor of the Upper Limb

United States, Canada, Poland
Jakub Antczak
Centrum Neurologii Klinicznej Krakowska Akademia Neurologii

Completed

Validation of the Polish Version of the Boston Carpal Tunnel Syndrome Questionnaire

Carpal Tunnel Syndrome

Poland
Poznan University of Medical Sciences

Completed

The Effectiveness of Physical Therapy Modalities in Carpal Tunnel Syndrome

Carpal Tunnel Syndrome

Poland
Merck KGaA, Darmstadt, Germany

Completed

Effects of Cladribine Tablets on the PK of Microgynon®

Relapsing Multiple Sclerosis (RMS)

Germany, Poland

Clinical Trials on Optic Nerve Hypoplasia and Abnormalities of the Central Nervous System in Poland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations